Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
399 USD | +0.33% | +1.05% | -2.08% |
Apr. 25 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $497 From $515 | MT |
Apr. 23 | Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.08% | 103B | |
+0.52% | 95.71B | |
+1.69% | 22.02B | |
-16.80% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-15.00% | 15.52B | |
+3.65% | 13.86B | |
+33.95% | 12.04B | |
-25.98% | 8.08B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals : SVB Leerink Adjusts Vertex Pharmaceuticals' Price Target to $175 From $170; Underperform Rating Kept